<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>883</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11238655</PubmedId>
            <Abstract>Listeria monocytogenes is an intracellular bacterium that causes systemic infections after traversing the intestinal mucosa. Clearance of infection and long term protective immunity are mediated by L. monocytogenes-specific CD8 T lymphocytes. In this report, we characterize the murine CD8 T cell response in the lamina propria and intestinal epithelium after enteric L. monocytogenes infection. We find that the frequency of MHC class Ia-restricted, L. monocytogenes-specific T cells is approximately 4- to 5-fold greater in the lamina propria than in the spleen of mice after oral or i.v. infection. Although the kinetics of T cell expansion and contraction are similar in spleen, lamina propria, and intestinal epithelium, high frequencies of Ag-specific T cells are detected only in the lamina propria 1 mo after infection. In contrast to MHC class Ia-restricted T cells, the frequency of H2-M3-restricted, L. monocytogenes-specific T cells is decreased in the intestinal mucosa relative to that found in the spleen. In addition to this disparity, we find that MHC class Ia-restricted CD8 T cells specific for a dominant L. monocytogenes epitope have different TCR V beta repertoires in the spleen and intestinal mucosa of individual mice. These findings indicate that the intestinal mucosa is a depot where L. monocytogenes-specific effector CD8 T cells accumulate during and after infection irrespective of immunization route. Furthermore, our results demonstrate that CD8 T cell populations in these two sites, although overlapping in Ag specificity, are distinct in terms of their repertoire.</Abstract>
            <ArticleYear>2001</ArticleYear>
            <ArticlePages>4065-73</ArticlePages>
            <ArticleTitle>Intestinal and splenic T cell responses to enteric Listeria monocytogenes infection: distinct repertoires of responding CD8 T lymphocytes.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Huleatt</LastName>
                    <ForeName>J W</ForeName>
                </Author>
                <Author>
                    <LastName>Pilip</LastName>
                    <ForeName>I</ForeName>
                </Author>
                <Author>
                    <LastName>Kerksiek</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Pamer</LastName>
                    <ForeName>E G</ForeName>
                </Author>
            </Authors>
            <Affiliations>Section of Infectious Diseases, Yale School of Medicine, New Haven, CT 06520, USA. James.Huleatt@Yale.edu.</Affiliations>
            <ArticleChemicalList>Bacterial Toxins;Epitopes, T-Lymphocyte;Heat-Shock Proteins;Hemolysin Proteins;Histocompatibility Antigens Class I;Peptide Fragments;Receptors, Antigen, T-Cell, alpha-beta;hlyA protein, Listeria monocytogenes</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Bacterial Toxins; CD8-Positive T-Lymphocytes(immunology; metabolism; microbiology; pathology); Cell Division(immunology); Cytotoxicity, Immunologic; Enteritis(immunology; microbiology; pathology); Epitopes, T-Lymphocyte(analysis); Female; Heat-Shock Proteins(immunology); Hemolysin Proteins; Histocompatibility Antigens Class I(immunology); Immunization; Injections, Intravenous; Intestinal Mucosa(immunology; microbiology; pathology); Intestine, Small(immunology; microbiology; pathology); Intubation, Gastrointestinal; Kinetics; Listeria monocytogenes(growth &amp; development; immunology); Listeriosis(immunology; microbiology; pathology); Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Peptide Fragments(immunology); Receptors, Antigen, T-Cell, alpha-beta(biosynthesis); Spleen(immunology; microbiology; pathology); T-Lymphocyte Subsets(immunology; metabolism; microbiology; pathology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>166</Volume>
                <Issue>6</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>LLO91-99</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GYKDGNEYI</LinearSequence>
                        <StartingPosition>91</StartingPosition>
                        <EndingPosition>99</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P13128.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>393133</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 5</LocationOfData>
                <EpitopeId>23376</EpitopeId>
                <ReferenceStartingPosition>91</ReferenceStartingPosition>
                <ReferenceEndingPosition>99</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Immunodominant MHC class I epitope from source protein during infection of H-2 Kd with source species. This study shows that H-2 Kd restricted peptide specific responses are prevalent in intestinal lamina propia (LP), with higher numbers, cytotoxic activity and duration than in spleen or intestinal epithelium. Protein name stands for Listeriolysin O precursor, Also known as Thiol-activated cytolysin.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <TCellId>9996</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>393133</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Oral</Route>
                                <DoseSchedule>1 dose of 10,sup&gt;9&lt;/sup&gt; CFU given orally or of 10^4 CFU intravenously.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>9 days after infection, cells from LP, IE or spleen were used for tetramer staining.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Gastrointestinal Tract</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>LLO91-99</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GYKDGNEYI</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>99</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P13128.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>393133</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope specific CD8+ TCRαβ+ T cells are more prevalent in intestinal lamina propia (LP) than in intestinal epithelium (IE) or spleen, and are absent from mesenterial lymph node. This is seen both in orally and i.v. infected mice 9 days after infection. In the IE, it was shown that the LLO -specific cells were CD8αβ+. The peptide specific T cell population contracted after the 9th day after infection with a 3% remaining population at day 30 detectable in LP while undetectable in IE or spleen. This was similarly seen in i.v infected animals. The Vβ repertoire analysis from the different tissues reveals that different variants are expressed by LP and spleen CD8+ cells, irrespective of the infection route.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <TCellId>10001</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>393133</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Oral</Route>
                                <DoseSchedule>1 dose of 10,sup&gt;9&lt;/sup&gt; CFU given orally or of 10^4 CFU intravenously.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>9 days after infection, cells from LP, IE or spleen were used for cytotoxic activity determination.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Gastrointestinal Tract</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>P815-Mast cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                            <SourceOrganismId>10000055</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>LLO91-99</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GYKDGNEYI</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>99</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P13128.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>393133</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope specific CD8+ T cells from intestinal lamina propia (LP) lyse peptide-pulsed target T cells more strongly than T cells from spleen. Lytic activity is absent from intestinal epithelium (IE) T cells. This is seen 9 days after infection, both in orally and i.v. infected mice, but orally infected mice had higher responses than i.v. infected mice in LP T cells, while the pattern of reactivity was inverse in spleen, with higher responses in the i.v infected mice.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>p60 217-225</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KYGVSVQDI</LinearSequence>
                        <StartingPosition>217</StartingPosition>
                        <EndingPosition>225</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P21171.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1639</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 5</LocationOfData>
                <EpitopeId>34446</EpitopeId>
                <ReferenceStartingPosition>217</ReferenceStartingPosition>
                <ReferenceEndingPosition>225</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Immunodominant MHC class I epitope from source protein during infection of H-2 Kd with source species. This study shows that H-2 Kd restricted peptide specificCD8+ T cells are more abundant in intestinal lamina propia (LP) than in spleen or intestinal epithelium.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <TCellId>10006</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1639</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Oral</Route>
                                <DoseSchedule>1 dose of 10,sup&gt;9&lt;/sup&gt; CFU</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>9 days after infection, cells from LP, IE or spleen were used for tetramer staining.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Gastrointestinal Tract</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>p60 217-225</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KYGVSVQDI</LinearSequence>
                                        <StartingPosition>217</StartingPosition>
                                        <EndingPosition>225</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P21171.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1639</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope specific CD8+ TCRαβ+ T cells are more prevalent in intestinal lamina propia (LP) than in intestinal epithelium (IE) or spleen and are low in the mesenterial lymph node.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>fMIGWII</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MIGWII</LinearSequence>
                        <ModifiedResidues>M1</ModifiedResidues>
                        <Modifications>Formylation|FORM</Modifications>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>6</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q8Y8E2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1639</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 5</LocationOfData>
                <EpitopeId>41710</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>6</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>M3 restricted peptide from L. monocytogenes, requiring N-terminus formyl-methionine for MHC binding. This study shows that H-2 M3 restricted peptide specific CD8+ T cells are more abundant in spleen than in intestinal lamina propia (LP), and are absent from intestinal epithelium (IE).</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <TCellId>10009</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>1639</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Oral</Route>
                                <DoseSchedule>1 dose of 10,sup&gt;9&lt;/sup&gt; CFU</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>9 days after infection, cells from LP, IE or spleen were used for tetramer staining.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>128</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>fMIGWII</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MIGWII</LinearSequence>
                                        <ModifiedResidues>M1</ModifiedResidues>
                                        <Modifications>Formylation|FORM</Modifications>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>6</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q8Y8E2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1639</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Epitope specific CD8+ TCRαβ+ T cells are more prevalent in spleen than in intestinal lamina propia (LP), are low in mesenterial lymph node, and absent in intestinal epithelium (IE).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

